insights_auto
Why is CBIO down 2.65%?
Dive Deeperchevron_right
CBIO:NASDAQ
Crescent Biopharma Inc
$13.57
arrow_downward
-2.65%(-0.37) 1D
$13.57
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CBIO...
Open
$14.78
High
$14.93
Low
$13.46
Mkt. cap
517.78M
Avg. vol.
451.70K
Volume
0.00
52-wk high
$27.41
52-wk low
$8.72
EPS
-$7.41
Beta
1.27
Shares outstanding
37.14M
No. of employees
69
Open
$14.78
High
$14.93
Low
$13.46
Mkt. cap
517.78M
Avg. vol.
451.70K
Volume
0.00
52-wk high
$27.41
52-wk low
$8.72
EPS
-$7.41
Beta
1.27
Shares outstanding
37.14M
No. of employees
69
News stories
From web sources and news partners
Stock Titan
·
11 hours ago
Six employees can buy Crescent shares for $13.94 each once their options vest.
Investing.com
·
18 hours ago
Stifel reiterates Buy on Crescent Biopharma stock, $28 target
Investing.com
·
19 hours ago
Crescent Biopharma stock rating upgraded to buy at H.C. Wainwright
Stock Titan
·
1 day ago
The FDA clears an application to test Crescent’s cancer treatment in people.
About Crescent Biopharma Inc
CEO-
Employees69
Founded2024
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitecrescentbiopharma.com